Skip to main content
Fig. 3 | Trials

Fig. 3

From: Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

Fig. 3

LAKANA trial adaptive design. LAKANA, Large-scale Assessment of the Key health-promoting Activities of two New mass drug administration regimens with Azithromycin; MDA, mass drug administration; SMC, seasonal malaria chemoprevention

Back to article page

Trials

ISSN: 1745-6215